Clinical Surgical Oncology最新文献

{"title":"Individualized surgical approach based on Bismuth-Corlette classification for perihilar cholangiocarcinoma","authors":"I-Chin Lee ,&nbsp;Björn-Ole Stüben ,&nbsp;Mohammad Fard-Aghaie ,&nbsp;Anastasios Giannou ,&nbsp;Tarik Ghadban ,&nbsp;Asmus Heumann ,&nbsp;Jun Li","doi":"10.1016/j.cson.2024.100057","DOIUrl":"10.1016/j.cson.2024.100057","url":null,"abstract":"<div><p>Perihilar cholangiocarcinoma, a formidable adversary in the field of hepatobiliary surgery, presents multifaceted challenges. This paper reviews its historical context, classification criteria, and regional variations in definition. It emphasizes the critical role of preoperative assessment, including hepatic hilum anatomy, biliary infiltration characteristics, and residual liver volume evaluation. The impact of the Bismuth-Corlette classification on surgical approach selection is elucidated, providing insights into tailored surgical options for each subtype based on the authors’ center experience in the last ten years. The article also touches upon laparoscopic and robotic surgery potential, underscoring the need for further research in this domain. Finally, it explores the potential role of liver transplantation as a treatment option for select patients ineligible for conventional surgery.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"3 3","pages":"Article 100057"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X24000254/pdfft?md5=6d80f38e00063e26d79cf9abf67d9bf0&pid=1-s2.0-S2773160X24000254-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142149577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Liquid biopsy for monitoring minimal residual disease in colorectal cancer: A promising approach with clinical implications","authors":"Zhexue Wang ,&nbsp;Junge Bai ,&nbsp;Dedi Jiang ,&nbsp;Yuegang Li ,&nbsp;Xiyue Hu ,&nbsp;Sergey Efetov ,&nbsp;Yu Cao ,&nbsp;Cuneyt Kayaalp ,&nbsp;Audrius Dulskas ,&nbsp;Darcy Shaw ,&nbsp;Ming Yang ,&nbsp;Zheng Liu ,&nbsp;Xishan Wang","doi":"10.1016/j.cson.2024.100056","DOIUrl":"10.1016/j.cson.2024.100056","url":null,"abstract":"<div><p>Colorectal cancer (CRC) is a global health concern, ranking among the leading causes of cancer-related mortality. This review critically evaluates the role of liquid biopsy in detecting minimal residual disease (MRD) in CRC. The increasing incidence, particularly in China, highlights the urgency of innovative approaches for early prediction of recurrence and metastasis. The importance of MRD should be underscored as residual tumor cells post-treatment significantly impact patient prognosis. Liquid biopsy methods, including circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and circulating tumor RNA, are dissected for their potential in identifying molecular markers associated with CRC. The focus on ctDNA highlights its non-invasive nature, real-time monitoring capabilities, and superiority over traditional detection methods in terms of sensitivity and timeliness. The review also delves into the limitations, such as clonal hematopoiesis and the critical consideration of optimal timing for postoperative ctDNA detection. In conclusion, the review highlights the significant potential of liquid biopsy, particularly ctDNA, as a dynamic and non-invasive tool for MRD detection in CRC. By complementing traditional methods, liquid biopsy contributes to precision in tumor research and personalized treatment. These advancements offer promising avenues for improving CRC patient prognosis and tailoring individualized treatment strategies.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"3 3","pages":"Article 100056"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X24000242/pdfft?md5=7deada45477b79742f5dd072adc52c92&pid=1-s2.0-S2773160X24000242-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142149578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Surgical frontiers in metastatic disease: Shaping cancer care","authors":"Mark Alexander Taylor","doi":"10.1016/j.cson.2024.100055","DOIUrl":"10.1016/j.cson.2024.100055","url":null,"abstract":"","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"3 3","pages":"Article 100055"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X24000230/pdfft?md5=c54e844c551ffe0fc5feb7e4e95c9213&pid=1-s2.0-S2773160X24000230-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141839562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnostic sensitivity of immune-inflammatory cell proportion in early diagnosis of endometrial cancer","authors":"Li Sun ,&nbsp;Shujie Zhai ,&nbsp;Guojia Wu ,&nbsp;Jie Gu ,&nbsp;Yiran Huang ,&nbsp;Dandan Hong ,&nbsp;Jianmei Wang ,&nbsp;Yongmei Li","doi":"10.1016/j.cson.2024.100058","DOIUrl":"10.1016/j.cson.2024.100058","url":null,"abstract":"<div><h3>Background</h3><p>Previous studies have shown that inflammation is closely linked to the occurrence and progression of cancer. While the role of immune-inflammatory cell proportions in cancer prognosis has been demonstrated, further research is required to fully understand their predictive value. This study aims to investigate the potential of immune-inflammatory cell proportions, such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), red blood cell distribution width-to-platelet ratio (RPR), and monocyte-to-lymphocyte ratio (MLR), in predicting endometrial cancer (EC).</p></div><div><h3>Methods</h3><p>In this study, 18 patients with EC were included to create receiver operating characteristic (ROC) curves for NLR, MLR, PLR, and RPR, and the area under the curve (AUC) was calculated. Binary LOGISTIC regression analysis was then used to develop composite indicators. Subsequently, ROC curves were generated for the combined indicators, and the corresponding AUCs were calculated to evaluate the diagnostic efficacy of NLR, MLR, PLR, and RPR individually and in combination. The model was validated in an additional cohort.</p></div><div><h3>Result</h3><p>In the single-indicator ROC analysis, the baseline AUC for NLR was 0.724, with a significance level of <em>p</em> ​&lt; ​0.05, indicating good predictive power. For the two-indicator combined ROC analysis, the combined AUC of NLR with each of the three other indicators was greater than 0.724 with a significance level of <em>p</em> ​&lt; ​0.05. In the three-indicator combined ROC analysis, the baseline AUC of the combined indicators (including NLR) was greater than 0.766, and a <em>p</em> value of 0.001. Moreover, the baseline AUC of the validation set was 0.726.</p></div><div><h3>Conclusion</h3><p>Our findings suggest that the immune-inflammatory cell ratios, especially NLR, have a good predictive value for EC. Furthermore, the combined predictive value of the immune-inflammatory cell ratio is more effective than using individual applications.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"3 3","pages":"Article 100058"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X24000266/pdfft?md5=a41404e3d16b6c42364faf4ca54363fd&pid=1-s2.0-S2773160X24000266-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Chinese expert consensus on the pelvic exenteration for primary rectal cancer beyond total mesorectal excision planes and locally recurrent rectal cancer","authors":"Meng Zhuang ,&nbsp;Yingchao Wu ,&nbsp;Bin Tang ,&nbsp;Jian Zhang ,&nbsp;Tenghui Ma ,&nbsp;Xicheng Wang ,&nbsp;Yuan Tang ,&nbsp;Yong Wu ,&nbsp;Xin Wang ,&nbsp;Xishan Wang ,&nbsp;Jianqiang Tang","doi":"10.1016/j.cson.2024.100053","DOIUrl":"10.1016/j.cson.2024.100053","url":null,"abstract":"<div><p>Pelvic exenteration is often required for primary rectal cancer beyond total mesorectal excision (PRC-bTME) and locally recurrent rectal cancer (LRRC). Some patients with radical resection can achieve long-term survival, but they need to face risks, such as huge surgical trauma, serious perioperative complications, permanent loss of organ function and decline in quality of life. Preoperative evaluation of PRC-bTME and LRRC should emphasize multidisciplinary collaboration and develop individualized diagnosis and treatment strategies. The principles of function preservation and risk-benefit balance in surgery oncology should be followed, and R₀ resection should be emphasized. Perioperative complications, surgical trauma and organ function loss should be minimized to achieve the best quality control and balance point. This consensus was formulated by the Colorectal Cancer Committee of the Chinese Medical Doctor Association and the Gastrointestinal Surgery Committee of China International Exchange and Promotive Association for Medical and Health Care. The draft was formed based on the summary of domestic and foreign research progress and expert experience. After discussion, review and modification by experts, an anonymous voting was conducted for each major opinion, and in-depth verification was carried out according to the principles of evidence-based medicine. Finally, the Chinese expert consensus on the pelvic exenteration with primary rectal cancer beyond total mesorectal excision planes and locally recurrent rectal cancer (2023 edition) was formed. This consensus mainly summarizes the indications and contraindications of pelvic exenteration (PE) for PRC-bTME and LRRC, preoperative diagnosis and evaluation, perioperative treatment, as well as the resection scope, surgical methods, reconstruction of related organs, safety and complications of PE, postoperative follow-up and other issues, in order to provide guidance for PE in patients with PRC-bTME and LRRC.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"3 3","pages":"Article 100053"},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X24000217/pdfft?md5=241911fb65a464f33f5d78b6e59475f2&pid=1-s2.0-S2773160X24000217-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141993041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Top 50 most influential publications in robotic-assisted pulmonary lobectomy","authors":"Lauren C. Ladehoff ,&nbsp;Kristie M. Labib ,&nbsp;Richard Rivera ,&nbsp;William J. West III ,&nbsp;Cole R. Fiedler ,&nbsp;Eric M. Toloza","doi":"10.1016/j.cson.2024.100054","DOIUrl":"10.1016/j.cson.2024.100054","url":null,"abstract":"<div><h3>Background</h3><p>Since the early 2000s, robotic-assisted surgery has evolved in the field of thoracic surgery, and robotic-assisted pulmonary lobectomy (RAPL) has become a popular and safe treatment method for patients seeking removal of lung cancer. The purpose of the current study was to identify and examine the top-50 most influential articles in RAPL from 2003 to 2021 using bibliometric analysis.</p></div><div><h3>Hypothesis, materials, and methods</h3><p>The Clarivate Web of Science Core Collection was systematically searched to gather data on RAPL. Descriptive information for each article was collected and reported using descriptive statistics. The terms “robotic” AND “pulmonary” AND “lobectomy” were used to search this database and returned 468 articles published since 2003.</p></div><div><h3>Results</h3><p>Bibliometric analysis of the top-50 most influential manuscripts concluded that these articles were published between the years 2003 and 2021 and were collectively cited 2476 times. Mean number of total citations per article was 49.5 (95% confidence interval [37.8, 61.2]). The most influential articles experienced greatest increase in citations in 2020 with 450 total citations and an average of 9.0 citations per article. Our analysis demonstrated an increase in total number of citations for RAPL from 2003 to 2021, and 68% of the most cited articles were published after 2016. All 50 articles were published in English, and the United States (32) and the People's Republic of China (6) had the top number of publications. The top affiliation was the University of Michigan with 6 publications. The most popular journals were Annals of Thoracic Surgery and the Journal of Thoracic and Cardiovascular Surgery, with 7 and 6, respectively, of the top 50 manuscripts.</p></div><div><h3>Conclusion</h3><p>Given the rising popularity of RAPL since 2003, a current list of the most influential articles in RAPL can provide a reference point to guide better practice and address future areas of thoracic research.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"3 3","pages":"Article 100054"},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X24000229/pdfft?md5=ccff1531ebef604d774c569d8ef1f8e9&pid=1-s2.0-S2773160X24000229-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141839634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of three new wireless non-radiation techniques for localisation of non-palpable breast cancer - An updated systematic review and pooled meta-analysis","authors":"Kumaresh Timma Subramanian ,&nbsp;Abdolazeem Elnour ,&nbsp;Vijay Kurup","doi":"10.1016/j.cson.2024.100051","DOIUrl":"https://doi.org/10.1016/j.cson.2024.100051","url":null,"abstract":"<div><p>With a logistical advantage, new wire-free procedures have simplified implantation and retrieval of non-palpable breast cancers with enhanced clinical outcomes. The objective of current systematic review and meta-analysis is to assess the clinical effectiveness between three new wireless non-radiation localisation techniques, such as <strong>Magseed</strong>, <strong>Radiofrequency identification TAG</strong> and <strong>Savi-scout reflector</strong> from published literature over a 3 year period. The study, following PRISMA guidelines, identified 26 studies from 2020 to 2022 involving 6275 innovative agents, analyzing three groups. Statistical analysis using Medcalc software showed a pooled positive margin rate of <strong>12.28% (95% CI, 10–15%</strong>) and a re-excision rate of <strong>11.29% (95%CI, 9–14%)</strong> for all three wireless group combined whereas studies that compare them with wire showed higher positive margin rate of <strong>14.87% (95% CI, 12–18%)</strong> and re-excision rate of <strong>16.23% (95% CI, 14–18%)</strong> for wire-guided localisation. Compared with odd's ratio, there was no statistical significance for margin involvement between WGL and novel agents <strong>OR 0.870 95% CI (0.707</strong>–<strong>1.071); z=-1.310 p=0.190;</strong> however, there was a statistical significance with fewer re-excision for wireless group <strong>OR 0.791; 95% CI (0.648</strong>–<strong>0.965); z=-2.309 p=0.021</strong>. In sub group analysis with kruskal-wallis test, there was no statistical significance between each group for both margin-positivity <strong>(p=0.797; Chi</strong>^{<strong>2</strong>} <strong>0.605)</strong> and re-excision rates (<strong>p=0.464; chi</strong>^{<strong>2</strong>}<strong>1.535)</strong>. Consolidated insertion and retrieval success for wireless group were <strong>98.13%</strong> and <strong>99.13</strong>% respectively whereas WGL had a similar retrieval success rate of <strong>99.63%.</strong> To establish the best localisation approach, future prospective randomised trials will be required to assess quantitative cost-effective analyses.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"3 3","pages":"Article 100051"},"PeriodicalIF":0.0,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X24000199/pdfft?md5=d109fb7dadd9ac34022192165d22242d&pid=1-s2.0-S2773160X24000199-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141539781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Selective inguinofemoral node dissection for stage III vulvar squamous cancer: Feasibility and safety","authors":"","doi":"10.1016/j.cson.2024.100050","DOIUrl":"10.1016/j.cson.2024.100050","url":null,"abstract":"<div><h3>Purpose</h3><div>To assess the feasibility and outcomes of selective inguinal lymph node dissection (ILND) in stage III vulvar squamous cancer.</div></div><div><h3>Methods</h3><div>This study was approved by the Committee of Fudan University Shanghai Cancer Center. Ninety-one patients with stage III vulvar squamous cancer between March 2018 and March 2021 were included in this study. Thirty-one patients chose radical excision with selective ILND while 60 patients received radical excision with complete ILND voluntarily. After surgery, all the patients received postoperative external beam radiotherapy (EBRT). All the patients were invited to fill out two questionnaires: the EORTC QLQ-C30 and a vulvar specific questionnaire.</div></div><div><h3>Results</h3><div>The median follow-up time was 34 (16–50) months. There was no statistical difference in recurrence (<em>p</em>＞0.05) or overall survival (<em>p</em>＞0.05) in the two groups. Moreover, no difference in overall quality of life was observed between the two groups. The major difference was the increase in complaints of edema and body image after complete ILND.</div></div><div><h3>Conclusions</h3><div>Patients who underwent selective ILND reported less treatment related morbidity without affecting survival and overall quality of life compared to those who underwent complete ILND. Selective ILND may be a reasonable alternative for stage III vulvar squamous cancer in the future.</div></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"3 4","pages":"Article 100050"},"PeriodicalIF":0.0,"publicationDate":"2024-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141395107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Langer's arch?","authors":"Georgi P. Georgiev","doi":"10.1016/j.cson.2024.100049","DOIUrl":"https://doi.org/10.1016/j.cson.2024.100049","url":null,"abstract":"","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"3 2","pages":"Article 100049"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X24000175/pdfft?md5=b5988e711570db73eef883a9d0be9f30&pid=1-s2.0-S2773160X24000175-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141292319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparation of single or staged surgical management in acute obstructive non-metastatic colorectal cancer patients aged over 75","authors":"Jian Cui ,&nbsp;Jinxin Shi ,&nbsp;Hao Feng ,&nbsp;Danian Tang ,&nbsp;Xianglong Cao ,&nbsp;Wenrui Xu ,&nbsp;Zijian Li ,&nbsp;Tao Yu ,&nbsp;Chunlong Wang ,&nbsp;Qi An ,&nbsp;Gang Zhao","doi":"10.1016/j.cson.2024.100048","DOIUrl":"https://doi.org/10.1016/j.cson.2024.100048","url":null,"abstract":"<div><h3>Purpose</h3><p>Management of obstructive colorectal cancer (OCRC) can be achieved through either emergent resection of the primary tumor (single operation), or the creation of temporary decompression stoma or self-expandable metallic stents (SEMS) insertion followed by tumor resection (staged procedure). The aim of the study was to compare the short-term outcomes of single and staged surgery in acute non-metastatic elderly OCRC patients.</p></div><div><h3>Methods</h3><p>Twenty-two elderly patients (aged over 75) scheduled to receive either single surgery (n ​= ​14) or staged surgery (n ​= ​8) for the management of acute OCRC were enrolled from 2012 to 2017. The stoma rate, postoperative complications were compared.</p></div><div><h3>Results</h3><p>The stoma rate was 42.9% in single surgery group and 25% in SEMS group. No difference was found in the rate of total complications (50% vs 25%, <em>P</em> ​= ​0.25). In the single surgery group, four patients (28.6%) experienced SSIs, and pneumonia occurred in three patients (21.4%), whereas none of the patient in staged surgery had infection related complication. Overall, the rate of infection related complication in single surgery group (50%) was significantly higher than that in staged surgery group (P ​= ​0.015).</p></div><div><h3>Conclusions</h3><p>Either single or stage surgery is feasible for acute elderly OCRC patients. However, single surgery is associated with significant increase in infection related complication.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"3 2","pages":"Article 100048"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X24000163/pdfft?md5=d4673fd94bd826626e1ea68c4af3a90e&pid=1-s2.0-S2773160X24000163-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141424018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}